Livzon Pharmaceutical repurchases shares in May 2025

Livzon Pharmaceutical Group (SZSE:000513) announced changes in its issued share capital for May 2025. The company repurchased 7,245,300 H-shares at HKD 26.32 per share, and these shares were subsequently canceled. This decreased the total issued H-shares to 299,807,117. Livzon also reported that 5,283,750 A-shares and 1,000,000 A-shares, previously granted under the 2022 stock option incentive plan, were canceled. The total number of issued A-shares remains at 604,293,313. The company's total registered share capital is RMB 904,100,430. As of the end of May, 11,318,855 A-shares will be repurchased but not yet cancelled.